September 2018


Products that could change how you practice

by Steve Speares ASCRS Executive Director

Vance Thompson, MD, Refractive editor

I think ophthalmology is one of the most exciting specialties in medicine because of the constant innovations in helping patients with what many consider the most precious sense, their vision. The focus of this issue of EyeWorld is to teach ophthalmic surgeons about possible game changers in technologies, ones that could impact practices in significant ways.
The Light Adjustable Lens (RxSight, Aliso Viejo, California) is FDA approved, and commercial release is around the corner. EyeWorld spoke with David Chang, MD, Robert Maloney, MD, John Doane, MD, and Kevin Waltz, MD, all renowned experts in this surgical arena, to discuss the mechanism of light adjustability and its accuracy, permanency, and high rate of patient satisfaction. I was an investigator in the U.S. clinical trials, and I think this technology is poised to benefit many.
Another recently approved technology is the TrueTear neurostimulation device (Allergan, Dublin, Ireland), which helps dry eye patients use their body’s natural mechanisms to produce more tears. William Faulkner, MD, beautifully explains TrueTear’s ability to stimulate the production of physiologic tears. Thank you also to John Sheppard, MD, Stephen Pflugfelder, MD, and Richard Lewis, MD, for teaching us more about the neurostimulation mechanism of action and how it can uniquely increase all three vital layers of the tear film. This lubrication, in a uniquely physiologic fashion, is a step forward for dry eye patients.
Glaucoma affects many for multiple reasons including the side effects of drops and surgery and the difficulty of titrating therapy to individual needs. Balance Goggles (Equinox, Sioux Falls, South Dakota) are an exciting technology being developed to noninvasively and precisely lower IOP on demand. Thank you to John Berdahl, MD, Russell Swan, MD, and Malik Kahook, MD, for teaching us how these goggles work to lower IOP and why CSF pressure matters. I think it is exciting that these goggles can potentially treat glaucoma alone or in combination with medical and surgical therapy.
Tremendous research has been put into furthering vision and technology options for cataract surgery patients. Cataract and refractive surgery have come together in premium implant surgery. It has been said that besides the implant calculation itself, the capsulotomy plays the most important role in visual and refractive outcomes because of its influence on effective lens position. Dr. Waltz, Dr. Swan, and Florian Kretz, MD, along with co-inventor David Sretavan, MD, teach us about the Zepto capsulotomy system (Mynosys Cellular Devices, Fremont, California). How Zepto fits in a world dominated by manual capsulorhexis with a smaller role played by femtosecond laser-created capsulotomies is discussed. I think there is room for all three, and this article helps us further our knowledge on how Zepto is growing in our world of cataract surgery.
Anesthesia in cataract surgery is a subject of great interest to our surgical patients. Patients interested in options other than having an IV are excited to hear about MKO Melt (Imprimis Pharmaceuticals, San Diego). Dr. Berdahl, Mike Greenwood, MD, and Chris Bender, CRNA, share what the MKO Melt consists of, its advantages/disadvantages, and how their patients’ satisfaction with their cataract surgery journey has been impacted in a positive way.
EyeWorld salutes the physicians who have contributed to this issue
and thanks them for their expertise and willingness to share their stories.
I hope you enjoy reading what I consider one of the most exciting issues of EyeWorld that I have had the honor of being involved with.

Products that could change how you practice Products that could change how you practice
Ophthalmology News - EyeWorld Magazine
283 110
283 110
True, 9